Relationship between macular pigment and visual acuity in eyes with early age‐related macular degeneration
. Purpose: Today the extent to which MP impacts visual function in early AMD remains unclear. This study examines the relationship between macular pigment optical density (MPOD) and high‐contrast visual acuity (HC‐VA) and low‐contrast visual acuity (LC‐VA) in eyes with early age‐related macular deg...
Saved in:
| Published in | Acta ophthalmologica (Oxford, England) Vol. 91; no. 4; pp. e298 - e303 |
|---|---|
| Main Authors | , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Oxford, UK
Blackwell Publishing Ltd
01.06.2013
Wiley Subscription Services, Inc |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1755-375X 1755-3768 1755-3768 |
| DOI | 10.1111/aos.12067 |
Cover
Loading…
| Abstract | .
Purpose: Today the extent to which MP impacts visual function in early AMD remains unclear. This study examines the relationship between macular pigment optical density (MPOD) and high‐contrast visual acuity (HC‐VA) and low‐contrast visual acuity (LC‐VA) in eyes with early age‐related macular degeneration (AMD).
Methods: Measurements were made in 22 subjects with early AMD and 27 healthy control subjects. Distance best‐corrected VA was measured using HC (96%) and LC (10%) Bailey‐Lovie logMAR letter charts under photopic luminance conditions. MPOD was determined at the fovea through apparent motion photometry using the cathode ray tube‐based Metropsis psychophysical vision test (Cambridge Research Systems).
Results: No significant differences in foveal MPOD were detected between the control eyes (0.30 ± 0.24 log units) and eyes with early AMD (0.27 ± 0.15 log units). Neither were differences detected between the two groups in mean HC‐ and LC‐VA. Foveal MPOD showed significant correlation with both photopic HC‐VA (r = −0.47, p = 0.0008) and LC‐VA (r = −0.46, p = 0.0008) such that as MPOD increased, photopic HC‐VA and LC‐VA improved (lower logMAR values).
Conclusions: Low MP levels were related to worse visual function in both healthy eyes and eyes with early AMD. Our findings provide direction for future studies designed to improve retinal function through the use of oral supplements known to increase MP levels, especially in eyes with AMD and a low MPOD. |
|---|---|
| AbstractList | Today the extent to which MP impacts visual function in early AMD remains unclear. This study examines the relationship between macular pigment optical density (MPOD) and high-contrast visual acuity (HC-VA) and low-contrast visual acuity (LC-VA) in eyes with early age-related macular degeneration (AMD).
Measurements were made in 22 subjects with early AMD and 27 healthy control subjects. Distance best-corrected VA was measured using HC (96%) and LC (10%) Bailey-Lovie logMAR letter charts under photopic luminance conditions. MPOD was determined at the fovea through apparent motion photometry using the cathode ray tube-based Metropsis psychophysical vision test (Cambridge Research Systems).
No significant differences in foveal MPOD were detected between the control eyes (0.30 ± 0.24 log units) and eyes with early AMD (0.27 ± 0.15 log units). Neither were differences detected between the two groups in mean HC- and LC-VA. Foveal MPOD showed significant correlation with both photopic HC-VA (r = -0.47, p = 0.0008) and LC-VA (r = -0.46, p = 0.0008) such that as MPOD increased, photopic HC-VA and LC-VA improved (lower logMAR values).
Low MP levels were related to worse visual function in both healthy eyes and eyes with early AMD. Our findings provide direction for future studies designed to improve retinal function through the use of oral supplements known to increase MP levels, especially in eyes with AMD and a low MPOD. Purpose: Today the extent to which MP impacts visual function in early AMD remains unclear. This study examines the relationship between macular pigment optical density (MPOD) and high‐contrast visual acuity (HC‐VA) and low‐contrast visual acuity (LC‐VA) in eyes with early age‐related macular degeneration (AMD). Methods: Measurements were made in 22 subjects with early AMD and 27 healthy control subjects. Distance best‐corrected VA was measured using HC (96%) and LC (10%) Bailey‐Lovie logMAR letter charts under photopic luminance conditions. MPOD was determined at the fovea through apparent motion photometry using the cathode ray tube‐based Metropsis psychophysical vision test (Cambridge Research Systems). Results: No significant differences in foveal MPOD were detected between the control eyes (0.30 ± 0.24 log units) and eyes with early AMD (0.27 ± 0.15 log units). Neither were differences detected between the two groups in mean HC‐ and LC‐VA. Foveal MPOD showed significant correlation with both photopic HC‐VA ( r = −0.47, p = 0.0008) and LC‐VA ( r = −0.46, p = 0.0008) such that as MPOD increased, photopic HC‐VA and LC‐VA improved (lower logMAR values). Conclusions: Low MP levels were related to worse visual function in both healthy eyes and eyes with early AMD. Our findings provide direction for future studies designed to improve retinal function through the use of oral supplements known to increase MP levels, especially in eyes with AMD and a low MPOD. Purpose: Today the extent to which MP impacts visual function in early AMD remains unclear. This study examines the relationship between macular pigment optical density (MPOD) and high-contrast visual acuity (HC-VA) and low-contrast visual acuity (LC-VA) in eyes with early age-related macular degeneration (AMD). Methods: Measurements were made in 22 subjects with early AMD and 27 healthy control subjects. Distance best-corrected VA was measured using HC (96%) and LC (10%) Bailey-Lovie logMAR letter charts under photopic luminance conditions. MPOD was determined at the fovea through apparent motion photometry using the cathode ray tube-based Metropsis psychophysical vision test (Cambridge Research Systems). Results: No significant differences in foveal MPOD were detected between the control eyes (0.30 plus or minus 0.24 log units) and eyes with early AMD (0.27 plus or minus 0.15 log units). Neither were differences detected between the two groups in mean HC- and LC-VA. Foveal MPOD showed significant correlation with both photopic HC-VA (r=-0.47, p=0.0008) and LC-VA (r=-0.46, p=0.0008) such that as MPOD increased, photopic HC-VA and LC-VA improved (lower logMAR values). Conclusions: Low MP levels were related to worse visual function in both healthy eyes and eyes with early AMD. Our findings provide direction for future studies designed to improve retinal function through the use of oral supplements known to increase MP levels, especially in eyes with AMD and a low MPOD. Purpose: Today the extent to which MP impacts visual function in early AMD remains unclear. This study examines the relationship between macular pigment optical density (MPOD) and high-contrast visual acuity (HC-VA) and low-contrast visual acuity (LC-VA) in eyes with early age-related macular degeneration (AMD). Methods: Measurements were made in 22 subjects with early AMD and 27 healthy control subjects. Distance best-corrected VA was measured using HC (96%) and LC (10%) Bailey-Lovie logMAR letter charts under photopic luminance conditions. MPOD was determined at the fovea through apparent motion photometry using the cathode ray tube-based Metropsis psychophysical vision test (Cambridge Research Systems). Results: No significant differences in foveal MPOD were detected between the control eyes (0.30±0.24 log units) and eyes with early AMD (0.27±0.15 log units). Neither were differences detected between the two groups in mean HC- and LC-VA. Foveal MPOD showed significant correlation with both photopic HC-VA (r=-0.47, p=0.0008) and LC-VA (r=-0.46, p=0.0008) such that as MPOD increased, photopic HC-VA and LC-VA improved (lower logMAR values). Conclusions: Low MP levels were related to worse visual function in both healthy eyes and eyes with early AMD. Our findings provide direction for future studies designed to improve retinal function through the use of oral supplements known to increase MP levels, especially in eyes with AMD and a low MPOD. [PUBLICATION ABSTRACT] Today the extent to which MP impacts visual function in early AMD remains unclear. This study examines the relationship between macular pigment optical density (MPOD) and high-contrast visual acuity (HC-VA) and low-contrast visual acuity (LC-VA) in eyes with early age-related macular degeneration (AMD).PURPOSEToday the extent to which MP impacts visual function in early AMD remains unclear. This study examines the relationship between macular pigment optical density (MPOD) and high-contrast visual acuity (HC-VA) and low-contrast visual acuity (LC-VA) in eyes with early age-related macular degeneration (AMD).Measurements were made in 22 subjects with early AMD and 27 healthy control subjects. Distance best-corrected VA was measured using HC (96%) and LC (10%) Bailey-Lovie logMAR letter charts under photopic luminance conditions. MPOD was determined at the fovea through apparent motion photometry using the cathode ray tube-based Metropsis psychophysical vision test (Cambridge Research Systems).METHODSMeasurements were made in 22 subjects with early AMD and 27 healthy control subjects. Distance best-corrected VA was measured using HC (96%) and LC (10%) Bailey-Lovie logMAR letter charts under photopic luminance conditions. MPOD was determined at the fovea through apparent motion photometry using the cathode ray tube-based Metropsis psychophysical vision test (Cambridge Research Systems).No significant differences in foveal MPOD were detected between the control eyes (0.30 ± 0.24 log units) and eyes with early AMD (0.27 ± 0.15 log units). Neither were differences detected between the two groups in mean HC- and LC-VA. Foveal MPOD showed significant correlation with both photopic HC-VA (r = -0.47, p = 0.0008) and LC-VA (r = -0.46, p = 0.0008) such that as MPOD increased, photopic HC-VA and LC-VA improved (lower logMAR values).RESULTSNo significant differences in foveal MPOD were detected between the control eyes (0.30 ± 0.24 log units) and eyes with early AMD (0.27 ± 0.15 log units). Neither were differences detected between the two groups in mean HC- and LC-VA. Foveal MPOD showed significant correlation with both photopic HC-VA (r = -0.47, p = 0.0008) and LC-VA (r = -0.46, p = 0.0008) such that as MPOD increased, photopic HC-VA and LC-VA improved (lower logMAR values).Low MP levels were related to worse visual function in both healthy eyes and eyes with early AMD. Our findings provide direction for future studies designed to improve retinal function through the use of oral supplements known to increase MP levels, especially in eyes with AMD and a low MPOD.CONCLUSIONSLow MP levels were related to worse visual function in both healthy eyes and eyes with early AMD. Our findings provide direction for future studies designed to improve retinal function through the use of oral supplements known to increase MP levels, especially in eyes with AMD and a low MPOD. . Purpose: Today the extent to which MP impacts visual function in early AMD remains unclear. This study examines the relationship between macular pigment optical density (MPOD) and high‐contrast visual acuity (HC‐VA) and low‐contrast visual acuity (LC‐VA) in eyes with early age‐related macular degeneration (AMD). Methods: Measurements were made in 22 subjects with early AMD and 27 healthy control subjects. Distance best‐corrected VA was measured using HC (96%) and LC (10%) Bailey‐Lovie logMAR letter charts under photopic luminance conditions. MPOD was determined at the fovea through apparent motion photometry using the cathode ray tube‐based Metropsis psychophysical vision test (Cambridge Research Systems). Results: No significant differences in foveal MPOD were detected between the control eyes (0.30 ± 0.24 log units) and eyes with early AMD (0.27 ± 0.15 log units). Neither were differences detected between the two groups in mean HC‐ and LC‐VA. Foveal MPOD showed significant correlation with both photopic HC‐VA (r = −0.47, p = 0.0008) and LC‐VA (r = −0.46, p = 0.0008) such that as MPOD increased, photopic HC‐VA and LC‐VA improved (lower logMAR values). Conclusions: Low MP levels were related to worse visual function in both healthy eyes and eyes with early AMD. Our findings provide direction for future studies designed to improve retinal function through the use of oral supplements known to increase MP levels, especially in eyes with AMD and a low MPOD. |
| Author | Palomo‐Alvarez, Catalina Barrio, Ana R. Gómez‐Sanz, Fernando J. Puell, María C. Pérez‐Carrasco, María Jesús |
| Author_xml | – sequence: 1 givenname: María C. surname: Puell fullname: Puell, María C. – sequence: 2 givenname: Catalina surname: Palomo‐Alvarez fullname: Palomo‐Alvarez, Catalina – sequence: 3 givenname: Ana R. surname: Barrio fullname: Barrio, Ana R. – sequence: 4 givenname: Fernando J. surname: Gómez‐Sanz fullname: Gómez‐Sanz, Fernando J. – sequence: 5 givenname: María Jesús surname: Pérez‐Carrasco fullname: Pérez‐Carrasco, María Jesús |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23575039$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkclq3TAYhUVJaYZ20Rcogm7axU00WJK9DKETBAIdoDshS79vFGT5VrJz8a6PkGfMk1R3SBahpdpIQt85PzrnGB3EIQJCryk5pWWdmSGfUkakeoaOqBJiwZWsDx7P4uchOs75hhBJpaxeoEPGhRKEN0cofIVgRj_EfO1XuIVxDRBxb-wUTMIrv-whjthEh299nkzA5cWPM_YRwwwZr_14jcGkMGOzhPvfd2njB-7RwsESIqTtjJfoeWdChlf7_QT9-Pjh-8XnxeXVpy8X55cLy2upFrauDTfKKieb1trOMtES6AQvFyMr55RSFRfctqZzpmPMEUE7UTPbGcGs4yfo3c53lYZfE-RR9z5bCMFEGKasaUUbLrlq2P_RklTVcMLqgr59gt4MU4rlIxtKFkvFeaHe7Kmp7cHpVfK9SbN-iLwAZzvApiHnBJ22ftzGMybjg6ZEb0rVpVS9LbUo3j9RPJj-jd27r32A-d-gPr_6tlP8AZN7syY |
| CitedBy_id | crossref_primary_10_1039_D0FO01483D crossref_primary_10_1111_aos_13106 crossref_primary_10_3390_nu8070426 crossref_primary_10_1093_nutrit_nuv005 crossref_primary_10_1167_iovs_18_24145 crossref_primary_10_3390_antiox10040601 crossref_primary_10_1097_IAE_0000000000000893 crossref_primary_10_1097_OPX_0000000000000834 crossref_primary_10_1097_MD_0000000000033280 crossref_primary_10_4102_aveh_v80i1_612 crossref_primary_10_1016_j_nutres_2016_02_007 crossref_primary_10_1136_bjophthalmol_2016_308418 crossref_primary_10_1111_aos_15131 crossref_primary_10_3390_nu10080959 |
| Cites_doi | 10.1001/archopht.1993.01090060119035 10.1001/archopht.1988.01060130061028 10.1167/iovs.10-6713 10.1016/j.exer.2010.09.015 10.1016/j.visres.2010.12.016 10.1167/iovs.07-1181 10.1002/1520-6378(2001)26:1 <::AID-COL56>3.0.CO;2-6 10.1016/S1529-1839(04)70049-4 10.1016/0042-6989(85)90123-3 10.1016/j.clnu.2008.01.003 10.1167/iovs.05-1235 10.1111/j.1444-0938.1989.tb06526.x 10.1016/j.visres.2010.04.009 10.1016/j.ophtha.2007.02.028 10.1364/JOSA.64.000231 10.1136/bjo.2007.135566 10.1186/1471-2415-6-23 10.1111/j.1475-1313.2010.00748.x 10.1136/bjo.2009.178137 10.1167/iovs.10-6699 10.1111/j.1475-1313.2006.00387.x 10.1111/j.1755-3768.2009.431.x 10.1016/j.visres.2009.10.014 10.1111/j.1755-3768.2008.01418.x 10.1167/iovs.04-0253 10.1093/ajcn/62.6.1448S 10.1097/OPX.0b013e318162266e 10.1016/S0002-9394(01)01218-1 10.1186/1471-2415-7-3 10.1167/iovs.11-7522 10.1016/S0161-6420(02)01173-9 10.1136/bjo.2009.175901 10.1111/j.1755-3768.2011.02170.x 10.1038/eye.2010.164 10.1016/S0899-9007(02)00861-4 10.1016/j.ophtha.2007.06.015 10.1111/j.1755-3768.2011.02294.x 10.1046/j.1475-1313.1996.96000129.x 10.1039/c0pp00126k 10.1167/iovs.08-3277 10.1111/j.1600-0420.2006.00759.x 10.1007/s00417-004-0995-7 10.1167/iovs.03-0762 10.1167/iovs.07-0933 10.1167/11.9.14 10.1007/s00417-006-0478-0 |
| ContentType | Journal Article |
| Copyright | 2013 Acta Ophthalmologica Scandinavica Foundation. Published by Blackwell Publishing Ltd 2013 Acta Ophthalmologica Scandinavica Foundation. Published by Blackwell Publishing Ltd. |
| Copyright_xml | – notice: 2013 Acta Ophthalmologica Scandinavica Foundation. Published by Blackwell Publishing Ltd – notice: 2013 Acta Ophthalmologica Scandinavica Foundation. Published by Blackwell Publishing Ltd. |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7TK 7X8 |
| DOI | 10.1111/aos.12067 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Neurosciences Abstracts MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Neurosciences Abstracts MEDLINE - Academic |
| DatabaseTitleList | MEDLINE CrossRef Neurosciences Abstracts Neurosciences Abstracts MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1755-3768 |
| EndPage | e303 |
| ExternalDocumentID | 2982704981 23575039 10_1111_aos_12067 AOS12067 |
| Genre | article Research Support, Non-U.S. Gov't Journal Article Comparative Study |
| GroupedDBID | --- .3N .55 .GA .Y3 05W 0R~ 10A 1OC 23M 24P 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCUV ABDBF ABEML ABJNI ABPVW ABQWH ABXGK ACAHQ ACCFJ ACCZN ACGFS ACGOF ACMXC ACNCT ACPOU ACPRK ACSCC ACUHS ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFFPM AFGKR AFPWT AFRAH AFWVQ AFZJQ AHBTC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BAWUL BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM E3Z EAD EAP EBC EBD EBS EJD EMB EMK EMOBN ESX EX3 F00 F01 F04 F5P FIJ FUBAC G-S GODZA H.X HF~ HGLYW HZI HZ~ IPNFZ IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OK1 OVD P2W P2X P2Z P4B P4D P6G PQQKQ Q.N Q11 QB0 R.K RIWAO RJQFR ROL RX1 SUPJJ SV3 TEORI TR2 TUS UB1 V9Y W8V W99 WBKPD WHWMO WIH WIJ WIK WIN WOHZO WOW WQJ WRC WVDHM WXI WXSBR X7M XG1 ~IA ~WT AAYXX AEYWJ AGHNM AGYGG CITATION AAMMB AEFGJ AGXDD AIDQK AIDYY CGR CUY CVF ECM EIF NPM 1OB 7TK 7X8 |
| ID | FETCH-LOGICAL-c3867-c88a3a7c7d69bccfc25b0ef53bcca64dd7774353cbafdaf22d051f582cfa52cd3 |
| IEDL.DBID | DR2 |
| ISSN | 1755-375X 1755-3768 |
| IngestDate | Fri Sep 05 00:45:28 EDT 2025 Thu Sep 04 18:14:54 EDT 2025 Wed Aug 13 09:55:59 EDT 2025 Mon Jul 21 06:05:34 EDT 2025 Thu Apr 24 23:04:45 EDT 2025 Tue Jul 01 00:24:36 EDT 2025 Wed Jan 22 16:38:15 EST 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 4 |
| Language | English |
| License | 2013 Acta Ophthalmologica Scandinavica Foundation. Published by Blackwell Publishing Ltd. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c3867-c88a3a7c7d69bccfc25b0ef53bcca64dd7774353cbafdaf22d051f582cfa52cd3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 |
| PMID | 23575039 |
| PQID | 1356193733 |
| PQPubID | 1036384 |
| PageCount | 6 |
| ParticipantIDs | proquest_miscellaneous_1419363792 proquest_miscellaneous_1357493028 proquest_journals_1356193733 pubmed_primary_23575039 crossref_citationtrail_10_1111_aos_12067 crossref_primary_10_1111_aos_12067 wiley_primary_10_1111_aos_12067_AOS12067 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | June 2013 2013-06-00 2013-Jun 20130601 |
| PublicationDateYYYYMMDD | 2013-06-01 |
| PublicationDate_xml | – month: 06 year: 2013 text: June 2013 |
| PublicationDecade | 2010 |
| PublicationPlace | Oxford, UK |
| PublicationPlace_xml | – name: Oxford, UK – name: England – name: Malden |
| PublicationTitle | Acta ophthalmologica (Oxford, England) |
| PublicationTitleAlternate | Acta Ophthalmol |
| PublicationYear | 2013 |
| Publisher | Blackwell Publishing Ltd Wiley Subscription Services, Inc |
| Publisher_xml | – name: Blackwell Publishing Ltd – name: Wiley Subscription Services, Inc |
| References | 2007; 245 2009; 87 1995; 39 1984; 25 2000; 41 2004; 45 2011; 52 2011; 11 2006; 6 2001; 26 2003; 19 1999; 40 1996; 16 2008; 92 1988; 106 2001; 42 1985; 25 2010; 88 2001; 132 1995; 62 1998; 39 1989; 72 2004; 75 2012; 90 1974; 64 2005; 243 2009; 50 2008; 27 2011; 95 2002; 43 2006; 47 2008; 49 2011; 51 2006; 26 2007; 7 1983 2008; 115 2011; 89 2008; 85 2002; 109 2011; 25 2010; 91 2010; 30 2010; 94 2010; 50 2010; 9 1993; 111 e_1_2_6_51_1 e_1_2_6_53_1 e_1_2_6_32_1 e_1_2_6_30_1 Wooten B (e_1_2_6_56_1) 1999; 40 Hammond BR (e_1_2_6_23_1) 1998; 39 e_1_2_6_19_1 e_1_2_6_13_1 e_1_2_6_36_1 e_1_2_6_11_1 e_1_2_6_34_1 e_1_2_6_17_1 e_1_2_6_55_1 e_1_2_6_38_1 e_1_2_6_43_1 e_1_2_6_20_1 e_1_2_6_41_1 Bone RA (e_1_2_6_15_1) 2001; 42 Anstis S (e_1_2_6_3_1) 1983 Berendschot TT (e_1_2_6_10_1) 2002; 43 e_1_2_6_5_1 e_1_2_6_7_1 e_1_2_6_24_1 e_1_2_6_22_1 e_1_2_6_28_1 e_1_2_6_45_1 Beatty S (e_1_2_6_9_1) 2001; 42 e_1_2_6_26_1 e_1_2_6_47_1 e_1_2_6_52_1 e_1_2_6_54_1 e_1_2_6_31_1 e_1_2_6_50_1 Ciulla TA (e_1_2_6_18_1) 2001; 42 e_1_2_6_14_1 e_1_2_6_35_1 e_1_2_6_12_1 e_1_2_6_33_1 e_1_2_6_39_1 e_1_2_6_16_1 e_1_2_6_37_1 e_1_2_6_42_1 e_1_2_6_40_1 Falsini B (e_1_2_6_21_1) 2000; 41 Snodderly DM (e_1_2_6_49_1) 1984; 25 e_1_2_6_8_1 e_1_2_6_4_1 e_1_2_6_6_1 e_1_2_6_25_1 e_1_2_6_48_1 e_1_2_6_2_1 e_1_2_6_29_1 e_1_2_6_44_1 e_1_2_6_27_1 e_1_2_6_46_1 |
| References_xml | – volume: 243 start-page: 222 year: 2005 end-page: 227 article-title: Macular pigment density in age‐related maculopathy publication-title: Graefes Arch Clin Exp Ophthalmol – volume: 50 start-page: 1249 year: 2010 end-page: 1256 article-title: The relationship between macular pigment and visual performance publication-title: Vision Res – volume: 91 start-page: 896 year: 2010 end-page: 900 article-title: The effect of macular pigment on heterochromatic luminance contrast publication-title: Exp Eye Res – volume: 19 start-page: 21 year: 2003 end-page: 24 article-title: Lutein, but not alpha‐tocopherol, supplementation improves visual function in patients with age‐related cataracts: a 2‐y double‐blind, placebo‐controlled pilot study publication-title: Nutrition – volume: 94 start-page: 753 year: 2010 end-page: 756 article-title: Clinical evaluation of the MPS 9000 macular pigment screener publication-title: Br J Ophthalmol – volume: 52 start-page: 8174 year: 2011 end-page: 8178 article-title: Effects of lutein supplementation on macular pigment optical density and visual acuity in patients with age‐related macular degeneration publication-title: Invest Ophthalmol Vis Sci – start-page: 66 year: 1983 end-page: 77 – volume: 25 start-page: 1531 year: 1985 end-page: 1535 article-title: Preliminary identification of the human macular pigment publication-title: Vision Res – volume: 106 start-page: 55 year: 1988 end-page: 57 article-title: Contrast sensitivity in age‐related macular degeneration publication-title: Arch Ophthalmol – volume: 42 start-page: 235 year: 2001 end-page: 240 article-title: Macular pigment in donor eyes with and without AMD: a case‐control study publication-title: Invest Ophthalmol Vis Sci – volume: 49 start-page: 2077 year: 2008 end-page: 2081 article-title: Foveal cone‐photoreceptor integrity in aging macula disorder publication-title: Invest Ophthalmol Vis Sci – volume: 132 start-page: 668 year: 2001 end-page: 681 publication-title: Am J Ophthalmol – volume: 92 start-page: 1163 year: 2008 end-page: 1168 article-title: The rationale and evidence base for a protective role of macular pigment in age‐related maculopathy publication-title: Br J Ophthalmol – volume: 85 start-page: 82 year: 2008 end-page: 88 article-title: Macular pigment and visual performance under glare conditions publication-title: Optom Vis Sci – volume: 7 start-page: 3 year: 2007 article-title: TOZAL Study: an open case control study of an oral antioxidant and omega‐3 supplement for dry AMD publication-title: BMC Ophthalmol – volume: 52 start-page: 3452 year: 2011 end-page: 3457 article-title: Determinants of macular pigment optical density and its relation to age‐related maculopathy: results from the Muenster Aging and Retina Study (MARS) publication-title: Invest Ophthalmol Vis Sci – volume: 26 start-page: 261 year: 2001 end-page: 265 article-title: Macular pigment assessment using a colour monitor publication-title: Color Res Appl – volume: 115 start-page: 147 year: 2008 end-page: 157 article-title: Macular carotenoid levels of normal subjects and age‐related maculopathy patients in a Japanese population publication-title: Ophthalmology – volume: 49 start-page: 2134 year: 2008 end-page: 2142 article-title: Spatial profile of macular pigment and its relationship to foveal architecture publication-title: Invest Ophthalmol Vis Sci – volume: 30 start-page: 470 year: 2010 end-page: 483 article-title: The Macular Assessment Profile test – a new VDU‐based technique for measuring the spatial distribution of the macular pigment, lens density and rapid flicker sensitivity publication-title: Ophthalmic Physiol Opt – volume: 72 start-page: 79 year: 1989 end-page: 83 article-title: High contrast and low contrast visual acuity in age related macular degeneration publication-title: Clin Exp Optom – volume: 245 start-page: 767 year: 2007 end-page: 773 article-title: Influence of macular pigment and melanin on incident early AMD in a white population publication-title: Graefes Arch Clin Exp Ophthalmol – volume: 9 start-page: 1418 year: 2010 end-page: 1425 article-title: Human ocular carotenoid‐binding proteins publication-title: Photochem Photobiol Sci – volume: 75 start-page: 216 year: 2004 end-page: 230 article-title: Double‐masked, placebo‐controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age‐related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial) publication-title: Optometry – volume: 42 start-page: 1338 year: 2001 end-page: 1341 article-title: Macular pigment optical density before and after cataract extraction publication-title: Invest Ophthalmol Vis Sci – volume: 95 start-page: 662 year: 2011 end-page: 665 article-title: Apparent motion photometry: evaluation and reliability of a novel method for the measurement of macular pigment publication-title: Br J Ophthalmol – volume: 88 start-page: 207 year: 2010 end-page: 211 article-title: Repeated measures of macular pigment optical density to test reproducibility of heterochromatic flicker photometry publication-title: Acta Ophthalmol – volume: 64 start-page: 231 year: 1974 end-page: 234 article-title: Macular pigment and chromatic aberration publication-title: J Opt Soc Am – volume: 111 start-page: 831 year: 1993 end-page: 836 article-title: The Lens Opacities Classification System III. The Longitudinal Study of Cataract Study Group publication-title: Arch Ophthalmol – volume: 50 start-page: 716 year: 2010 end-page: 728 article-title: The value of measurement of macular carotenoid pigment optical densities and distributions in age‐related macular degeneration and other retinal disorders publication-title: Vision Res – volume: 6 year: 2006 article-title: Lutein supplementation in retinitis pigmentosa: PC‐based vision assessment in a randomized double‐masked placebo‐controlled clinical trial [NCT00029289] publication-title: BMC Ophthalmol – volume: 39 start-page: 397 year: 1998 end-page: 406 article-title: Preservation of visual sensitivity of older subjects: association with macular pigment density publication-title: Invest Ophthalmol Vis Sci – volume: 90 start-page: e90 year: 2012 end-page: 97 article-title: An evaluation of a novel instrument for measuring macular pigment optical density: the MPS 9000 publication-title: Acta Ophthalmol – volume: 62 start-page: 1448S year: 1995 end-page: 1461S article-title: Evidence for protection against age‐related macular degeneration by carotenoids and antioxidant vitamins publication-title: Am J Clin Nutr – volume: 27 start-page: 218 year: 2008 end-page: 227 article-title: A randomised controlled trial investigating the effect of lutein and antioxidant dietary supplementation on visual function in healthy eyes publication-title: Clin Nutr – volume: 109 start-page: 1780 year: 2002 end-page: 1787 article-title: Resonance Raman measurement of macular carotenoids in normal subjects and in age‐related macular degeneration patients publication-title: Ophthalmology – volume: 50 start-page: 4777 year: 2009 end-page: 4785 article-title: Augmentation of macular pigment following implantation of blue light‐filtering intraocular lenses at the time of cataract surgery publication-title: Invest Ophthalmol Vis Sci – volume: 115 start-page: 876 year: 2008 end-page: 883.e871 article-title: Macular pigment density and age‐related maculopathy in the Carotenoids in Age‐Related Eye Disease Study. An ancillary study of the women’s health initiative publication-title: Ophthalmology – volume: 41 start-page: 1498 year: 2000 end-page: 1506 article-title: Retinal sensitivity to flicker modulation: reduced by early age‐related maculopathy publication-title: Invest Ophthalmol Vis Sci – volume: 25 start-page: 105 year: 2011 end-page: 112 article-title: Macular pigment optical density measurements: evaluation of a device using heterochromatic flicker photometry publication-title: Eye – volume: 51 start-page: 459 year: 2011 end-page: 469 article-title: The impact of macular pigment augmentation on visual performance in normal subjects: COMPASS publication-title: Vision Res – volume: 40 start-page: 2481 year: 1999 end-page: 2489 article-title: A practical method for measuring macular pigment optical density publication-title: Invest Ophthalmol Vis Sci – volume: 87 year: 2009 article-title: Repeatability in the measurement of macular pigment optical density using the Metropsis Test publication-title: Acta Ophthalmol – volume: 45 start-page: 3355 year: 2004 end-page: 3360 article-title: Flicker perimetry losses in age‐related macular degeneration publication-title: Invest Ophthalmol Vis Sci – volume: 52 start-page: 7406 year: 2011 end-page: 7415 article-title: Macular pigment and visual performance in glare: benefits for photostress recovery, disability glare, and visual discomfort publication-title: Invest Ophthalmol Vis Sci – volume: 47 start-page: 2329 year: 2006 end-page: 2335 article-title: Plasma lutein and zeaxanthin and other carotenoids as modifiable risk factors for age‐related maculopathy and cataract: the POLA Study publication-title: Invest Ophthalmol Vis Sci – volume: 89 start-page: e573 year: 2011 end-page: e578 article-title: Assessment of macular pigment optical density (MPOD) in patients with unilateral wet age‐related macular degeneration (AMD) publication-title: Acta Ophthalmol – volume: 39 start-page: 367 year: 1995 end-page: 374 article-title: An international classification and grading system for age‐related maculopathy and age‐related macular degeneration. The International ARM Epidemiological Study Group publication-title: Surv Ophthalmol – volume: 42 start-page: 439 year: 2001 end-page: 446 article-title: Macular pigment and risk for age‐related macular degeneration in subjects from a Northern European population publication-title: Invest Ophthalmol Vis Sci – volume: 11 start-page: 14 year: 2011 end-page: 21 article-title: Mesopic luminance assessed with minimum motion photometry publication-title: J Vis – volume: 45 start-page: 531 year: 2004 end-page: 538 article-title: Macular pigment measurement by heterochromatic flicker photometry in older subjects: the carotenoids and age‐related eye disease study publication-title: Invest Ophthalmol Vis Sci – volume: 25 start-page: 674 year: 1984 end-page: 685 article-title: The macular pigment. II. Spatial distribution in primate retinas publication-title: Invest Ophthalmol Vis Sci – volume: 43 start-page: 1928 year: 2002 end-page: 1932 article-title: Macular pigment and melanin in age‐related maculopathy in a general population publication-title: Invest Ophthalmol Vis Sci – volume: 16 start-page: 455 year: 1996 end-page: 459 article-title: Low contrast letter acuity in age‐related maculopathy publication-title: Ophthalmic Physiol Opt – volume: 26 start-page: 362 year: 2006 end-page: 371 article-title: Supplementation with the carotenoids lutein or zeaxanthin improves human visual performance publication-title: Ophthalmic Physiol Opt – ident: e_1_2_6_17_1 doi: 10.1001/archopht.1993.01090060119035 – volume: 41 start-page: 1498 year: 2000 ident: e_1_2_6_21_1 article-title: Retinal sensitivity to flicker modulation: reduced by early age‐related maculopathy publication-title: Invest Ophthalmol Vis Sci – ident: e_1_2_6_28_1 doi: 10.1001/archopht.1988.01060130061028 – ident: e_1_2_6_20_1 doi: 10.1167/iovs.10-6713 – ident: e_1_2_6_46_1 doi: 10.1016/j.exer.2010.09.015 – ident: e_1_2_6_39_1 doi: 10.1016/j.visres.2010.12.016 – ident: e_1_2_6_26_1 doi: 10.1167/iovs.07-1181 – ident: e_1_2_6_36_1 doi: 10.1002/1520-6378(2001)26:1 <::AID-COL56>3.0.CO;2-6 – ident: e_1_2_6_47_1 doi: 10.1016/S1529-1839(04)70049-4 – ident: e_1_2_6_14_1 doi: 10.1016/0042-6989(85)90123-3 – volume: 43 start-page: 1928 year: 2002 ident: e_1_2_6_10_1 article-title: Macular pigment and melanin in age‐related maculopathy in a general population publication-title: Invest Ophthalmol Vis Sci – volume: 42 start-page: 235 year: 2001 ident: e_1_2_6_15_1 article-title: Macular pigment in donor eyes with and without AMD: a case‐control study publication-title: Invest Ophthalmol Vis Sci – ident: e_1_2_6_6_1 doi: 10.1016/j.clnu.2008.01.003 – ident: e_1_2_6_19_1 doi: 10.1167/iovs.05-1235 – ident: e_1_2_6_35_1 doi: 10.1111/j.1444-0938.1989.tb06526.x – ident: e_1_2_6_33_1 doi: 10.1016/j.visres.2010.04.009 – ident: e_1_2_6_40_1 doi: 10.1016/j.ophtha.2007.02.028 – ident: e_1_2_6_45_1 doi: 10.1364/JOSA.64.000231 – ident: e_1_2_6_32_1 doi: 10.1136/bjo.2007.135566 – ident: e_1_2_6_4_1 doi: 10.1186/1471-2415-6-23 – ident: e_1_2_6_5_1 doi: 10.1111/j.1475-1313.2010.00748.x – ident: e_1_2_6_7_1 doi: 10.1136/bjo.2009.178137 – ident: e_1_2_6_52_1 doi: 10.1167/iovs.10-6699 – ident: e_1_2_6_29_1 doi: 10.1111/j.1475-1313.2006.00387.x – ident: e_1_2_6_42_1 doi: 10.1111/j.1755-3768.2009.431.x – volume: 42 start-page: 1338 year: 2001 ident: e_1_2_6_18_1 article-title: Macular pigment optical density before and after cataract extraction publication-title: Invest Ophthalmol Vis Sci – ident: e_1_2_6_12_1 doi: 10.1016/j.visres.2009.10.014 – volume: 25 start-page: 674 year: 1984 ident: e_1_2_6_49_1 article-title: The macular pigment. II. Spatial distribution in primate retinas publication-title: Invest Ophthalmol Vis Sci – ident: e_1_2_6_22_1 doi: 10.1111/j.1755-3768.2008.01418.x – ident: e_1_2_6_43_1 doi: 10.1167/iovs.04-0253 – ident: e_1_2_6_48_1 doi: 10.1093/ajcn/62.6.1448S – ident: e_1_2_6_51_1 doi: 10.1097/OPX.0b013e318162266e – ident: e_1_2_6_53_1 doi: 10.1016/S0002-9394(01)01218-1 – ident: e_1_2_6_16_1 doi: 10.1186/1471-2415-7-3 – ident: e_1_2_6_55_1 doi: 10.1167/iovs.11-7522 – ident: e_1_2_6_11_1 doi: 10.1016/S0161-6420(02)01173-9 – ident: e_1_2_6_8_1 doi: 10.1136/bjo.2009.175901 – volume: 40 start-page: 2481 year: 1999 ident: e_1_2_6_56_1 article-title: A practical method for measuring macular pigment optical density publication-title: Invest Ophthalmol Vis Sci – ident: e_1_2_6_54_1 doi: 10.1111/j.1755-3768.2011.02170.x – ident: e_1_2_6_27_1 doi: 10.1038/eye.2010.164 – ident: e_1_2_6_41_1 doi: 10.1016/S0899-9007(02)00861-4 – ident: e_1_2_6_30_1 doi: 10.1016/j.ophtha.2007.06.015 – ident: e_1_2_6_34_1 doi: 10.1111/j.1755-3768.2011.02294.x – ident: e_1_2_6_2_1 doi: 10.1046/j.1475-1313.1996.96000129.x – ident: e_1_2_6_31_1 doi: 10.1039/c0pp00126k – ident: e_1_2_6_38_1 doi: 10.1167/iovs.08-3277 – ident: e_1_2_6_13_1 doi: 10.1111/j.1600-0420.2006.00759.x – ident: e_1_2_6_24_1 doi: 10.1007/s00417-004-0995-7 – volume: 39 start-page: 397 year: 1998 ident: e_1_2_6_23_1 article-title: Preservation of visual sensitivity of older subjects: association with macular pigment density publication-title: Invest Ophthalmol Vis Sci – ident: e_1_2_6_50_1 doi: 10.1167/iovs.03-0762 – volume: 42 start-page: 439 year: 2001 ident: e_1_2_6_9_1 article-title: Macular pigment and risk for age‐related macular degeneration in subjects from a Northern European population publication-title: Invest Ophthalmol Vis Sci – ident: e_1_2_6_37_1 doi: 10.1167/iovs.07-0933 – ident: e_1_2_6_44_1 doi: 10.1167/11.9.14 – start-page: 66 volume-title: Colour Vision: Psychophysics and Physiology year: 1983 ident: e_1_2_6_3_1 – ident: e_1_2_6_25_1 doi: 10.1007/s00417-006-0478-0 |
| SSID | ssj0061664 |
| Score | 2.1267467 |
| Snippet | .
Purpose: Today the extent to which MP impacts visual function in early AMD remains unclear. This study examines the relationship between macular pigment... Purpose: Today the extent to which MP impacts visual function in early AMD remains unclear. This study examines the relationship between macular pigment... Today the extent to which MP impacts visual function in early AMD remains unclear. This study examines the relationship between macular pigment optical density... Purpose: Today the extent to which MP impacts visual function in early AMD remains unclear. This study examines the relationship between macular pigment... |
| SourceID | proquest pubmed crossref wiley |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | e298 |
| SubjectTerms | Aged age‐related macular degeneration Cell Count Disease Progression Female Follow-Up Studies Humans Macula Lutea - pathology Macula Lutea - physiopathology Macular Degeneration - pathology Macular Degeneration - physiopathology macular pigment optical density Male Middle Aged Ophthalmology Photometry Retinal Pigment Epithelium - pathology Vision Tests visual acuity Visual Acuity - physiology |
| Title | Relationship between macular pigment and visual acuity in eyes with early age‐related macular degeneration |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Faos.12067 https://www.ncbi.nlm.nih.gov/pubmed/23575039 https://www.proquest.com/docview/1356193733 https://www.proquest.com/docview/1357493028 https://www.proquest.com/docview/1419363792 |
| Volume | 91 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtQwFL2qukBseJTX0BYZxIJNRp7YjhN1VVGqCqkgAZVmgRT5cV1GlMyImakEq34C38iXcO081PISYpfIN45j-1wfO9fHAE-l0cbTLCez2oVMIsrM0jwk00Ygrzh3XMa9w8eviqMT-XKqphuw1--FafUhhgW3iIzkryPAjV1eArmZL8eTKD5O_nciiqibf_BmkI4qJkWSjqLRURGI1LRTFYpRPMOTV8eiXwjmVb6aBpzDm_C-L2obZ_JxvF7Zsfv6k4rjf37LLbjREVG23_ac27CBzRZcO-5-td-BsyFM7sNswbpwLvbJpLhVtpidxmVFZhrPzmfLNeVEKcTo2axh-AWXLC7wMozyyYxc1veLb2nXDPohC4-nSfI6vuMunBy-ePf8KOuOZsicKMm1urI0wminfVFZ54LLleUYlKAbU0jvNdFKoYSzJngT8twT-IMqcxeMyp0X92CzmTf4ABhHQY4OS5eHILGqbOV1ieiELQKxJz6CZ30j1a7TLY_HZ5zV_fyFaq9OtTeCJ4PpohXr-J3RTt_SdYdXShHEI4mpCTGCx0MyIS3-PjENztfJRstKECH7i42kXAqhq3wE99teNJQkCgspLir6oNQX_lzEev_123Tx8N9Nt-F63p7UkfHJDmyuPq9xl_jSyj5KwPgBlwMUWw |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JbhQxEC2FIAEX9mUggEEcuPTI07Z7kbhEQDRAJkiQSHNBLS_lMErSM2JmkODEJ_CNfAll9yLCJsStW652eyv7Vbn8DPBI6lw7snISk1ufSESZGLJDklwL5CXnlstwdniyl40P5Mupmm7Ak-4sTMMP0TvcgmbE-TooeHBI_6Dler4cjgL7-Bk4KwloBNPr2ZuePCobZZE8itZHRWqkpi2vUIjj6T89vRr9AjFPI9a45OxcgnddYZtIk6PhemWG9vNPPI7_W5vLcLHFomy7GTxXYAPrq3Bu0u62X4PjPlLu_WzB2ogudqJj6CpbzA6DZ5Hp2rGPs-WacqIUAvVsVjP8hEsWfLwMA4Myo1nr25ev8eAMuj4Lh4eR9Tr84zoc7DzffzpO2tsZEisKml1tUWihc5u7rDTWepsqw9ErQS86k87lhCyFEtZo77RPU0f671WRWq9Vap24AZv1vMZbwDgKmuuwsKn3EsvSlC4vEK0wmScAxQfwuOulyrbU5eEGjeOqM2Go9arYegN42IsuGr6O3wltdV1dtSpLKYKgJIE1IQbwoE8mZQs7KLrG-TrK5LIUhMn-IiMpl0zkZTqAm80w6ksSuIUUFyVVKA6GPxex2n79Nj7c_nfR-3B-vD_ZrXZf7L26AxfS5uKOhI-2YHP1YY13CT6tzL2oJd8ByWcYeg |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtQwFL0qRarY8KYMFDCIBZuMPLETJ-qqahmVRwsCKs0CKfLjuowomREzgwSrfgLfyJdw7TxEeQmxS-Qbx69jH9vXxwAPpVba0SwnMcr6RCLKxNA8JFFaIC85t1yGs8MHh_n-kXw6ySZrsN2dhWn0IfoFt4CM2F8HgM-d_wHkerYYjoL4-Dk4L3NiEoERveq1o_JRHrWjaHjMCEXZpJUVCm48_adnB6NfGOZZwhpHnPEleNultXE0eT9cLc3QfvlJxvE_M3MZLrZMlO00TecKrGF9FTYO2r32a3DS-8m9m85Z68_FPujouMrm0-Owrsh07din6WJFMVEIUXo2rRl-xgULK7wMg34yoz7r2-nXeGwGXR-Fw-OoeR3-cR2Oxo_f7O4n7d0MiRUF9a22KLTQyiqXl8Zab9PMcPSZoBedS-cU8UqRCWu0d9qnqSP0-6xIrddZap24Aev1rMabwDgK6umwsKn3EsvSlE4ViFaY3BN94gN41FVSZVvh8nB_xknVTWCo9KpYegN40JvOG7WO3xltdTVdtYClEEFEkqiaEAO43wcT1ML-ia5xtoo2SpaCGNlfbCTFkgtVpgPYbFpRn5KgLJRxUVKGYlv4cxKrnRev48Otfze9Bxsv98bV8yeHz27DhbS5tSPhoy1YX35c4R3iTktzN2LkO3o8Fyk |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Relationship+between+macular+pigment+and+visual+acuity+in+eyes+with+early+age-related+macular+degeneration&rft.jtitle=Acta+ophthalmologica+%28Oxford%2C+England%29&rft.au=Puell%2C+Mar%C3%ADa+C&rft.au=Palomo-Alvarez%2C+Catalina&rft.au=Barrio%2C+Ana+R&rft.au=G%C3%B3mez-Sanz%2C+Fernando+J&rft.date=2013-06-01&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=1755-375X&rft.eissn=1755-3768&rft.volume=91&rft.issue=4&rft.spage=e298&rft_id=info:doi/10.1111%2Faos.12067&rft.externalDBID=NO_FULL_TEXT&rft.externalDocID=2982704981 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1755-375X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1755-375X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1755-375X&client=summon |